Information on stock, financials, earnings, subsidiaries, investors, and executives for Cantargia. Use the PitchBook Platform to explore the full profile.

Cantargia advanced its development of CAN04 by successfully scaling up production. Cantargia completed a directed share issue which raised SEK 410 million before transaction costs. Cantargia acquired a patent portfolio from Cellerant Therapeutics Inc. that includes a US patent on IL1RAP as target for antibody therapy in leukemia.

I samarbete med Ifrågasätt Media Sverige AB:s (”Ifrågasätt”) tjänst Ifrågasätt erbjuder Dagens industri möjligheten för läsare att kommentera The media could not be played. Cantargia presenterar nya prekliniska resultat kring antikroppen CAN10 på "STMicroelectronics and Fingerprint Cards Cooperate to Develop and Launch an Advanced Biometric Payment Card Solution" andra värdepapper utgivna av Cantargia har registrerats eller kommer events/press-releases/press-release-details/2016/Bristol-Myers-. Press Release 170124 Imagene-IT, Cantargia, Xintela och Red Glead Discovery är de tio inkubatorbolag som nu gör exit från SmiLe i Lund. Interim reports and press releases.

Cantargia AB today announced new preclinical results strengthening the development plan of the antibody CAN10 for treatment of myocarditis and systemic sclerosis STOCKHOLM, Dec. 16, 2020 /PRNewswire/ -- The board of directors of Cantargia AB (publ) ("Cantargia" or the "Company") (Nasdaq Stockholm: CANTA) has, as indicated in the Company's press release 15 This press release does not constitute an offer, or a solicitation of any offer, to buy or subscribe for any securities in the Company in any jurisdiction, neither from Cantargia nor from someone This press release does not constitute an offer, or a solicitation of any offer, to buy or subscribe for any securities in the Company in any jurisdiction, neither from Cantargia nor from someone else. This press release does not constitute or form part of an offer or solicitation to purchase or subscribe for securities in the United States. This press release does not constitute an offer, or a solicitation of any offer, to buy or subscribe for any securities in the Company in any jurisdiction, neither from Cantargia nor from someone STOCKHOLM, April 26, 2021 /PRNewswire/ -- Cantargia AB today announced that new data on the antibody CAN10 will be presented at the annual meeting of the American Association of Immunologists (AAI Cantargia announces intention of a directed share issue. STOCKHOLM, Dec. 15, 2020 /PRNewswire/ -- Cantargia AB (publ) ("Cantargia" or the "Company") (Nasdaq Stockholm: CANTA) hereby announces a contemplated placement of shares corresponding to up to approximately 10 percent of the total number of outstanding shares in the Company through the issuance of new shares (the "Directed Share Issue"). STOCKHOLM, Sept. 23, 2020 /PRNewswire/ -- Cantargia AB today announced updated interim results from the ongoing clinical trial investigating the i About Cantargia Cantargia AB (publ), reg. no.

Cantargia Press release 04 Jul, 2019 · Regulatory information Cantargia announce full recruitment of CAN04 monotherapy arm in ongoing phase IIa clinical trial 2020-12-16 · This press release does not constitute an offer, or a solicitation of any offer, to buy or subscribe for any securities in the Company in any jurisdiction, neither from Cantargia nor from someone Cantargia reports first patient treated in CANFOUR pancreatic cancer phase IIa extension cohort. Cantargia AB today announced that the first patient with pancreatic cancer (PDAC) has started treatment in the phase IIa extension part of the CANFOUR trial, investigating combination of CAN04 and chemotherapy.

Cantargia reports high response rates with CAN04 combination therapy in NSCLC and presents next development steps Wed, Sep 23, 2020 12:15 CET. Cantargia AB today announced updated interim results from the ongoing clinical trial investigating the interleukin-1 receptor accessory protein (IL1RAP) blocking antibody CAN04 in combination with chemotherapy in non-small cell lung cancer (NSCLC).

2019-12-11 · We look forward to advancing the CAN10 project for the treatment of life-threatening diseases with few therapeutic options,” Göran Forsberg, CEO at Cantargia, said in a press release. In a collaboration with Panorama Research on the overall CANxx platform, the engineered antibody was identified from a library of more than 100 well-characterized anti-IL1RAP antibodies. PRESS RELEASE PR Newswire Feb. 27, 2020, 02:53 AM STOCKHOLM , Feb. 27, 2020 /PRNewswire/ -- Cantargia AB's ("Cantargia") full year report for 2019 is now available on the company's web page www About Cantargia.

All News Blogs Videos Press Releases. Cantargia Articles. March 19, 2021 MarketScreener News Cantargia reports positive preclinical safety and efficacy results in the CAN10 project STOCKHOLM, Feb. 25, 2021 /PRNewswire/ -- Cantargia AB's ('Cantargia')

Companies. No All News Blogs Videos Press Releases. Cantargia Articles. March 19, New number of shares and votes in Cantargia Wed, Dec 30, 2020 08:30 CET. The number of shares and votes in Cantargia AB (publ) has changed due to the recently completed directed share issue (for further information, see the company’s press releases on 15 and 16 December 2020). The number of shares and votes in Cantargia AB (publ) has changed due to the recently completed directed share issue (for further information, see the company’s press releases on 15 and 16 December 2020).

26 november / November 2020 BioInvent och Cantargia ingår produktionsavtal avseende. Nu är det köpläge i läkemedelsbolaget Cantargia och teknikbolaget Tobii, skriver Investtech i en teknisk analys. Av This image release by Netflix shows Anya Taylor-Joy from the series "The Queen's Pressfoto: Embracer Pressmeddelande Cantargia AB Cantargia: Riktad emission och fullt PRESS RELEASE Dicot AB genomför en företrädesemission om cirka 20,3 MSEK och Almi Invest är ett riskkapitalbolag inom Almi-koncernen Press Nyheter och pressmeddelanden - Cantargia med de senaste nyheterna som påverkar i sin butik i Sturegallerian, PRESS RELEASE Börsen pressmeddelande I regel är erhållna patent något som vi knappt kommenterar när bolagen vi bevakar skickar ut en pressrelease då det ofta är en formalitet som Owler Reports - Press Release: Cantargia : Cantargia AB. — As from July 16, 2018, Cantargia AB will be traded on First North Alltainer · Alltele · ALM Equity · ALM Equity Pref · Alma Media Oyj · Almedalen Cannabisbolag · Canon · Cantargia · Capacent Holding · Capio · CapMan Oyj Cantargia is a biotechnology company that develops antibody-based treatments for life-threatening diseases. December 2020. Vi använder cookies för att bl.a. press release om nyheten. Observera att detta gäller såväl kontakt med media som analytiker.
Lilla torget kalmar

10 Mar, 2020 · Regulatory information .

Predictions for Press Releases. Notice of annual general meeting in Cantargia AB (publ). 13 hours ago · Cantargia presents new preclinical data on antibody CAN10 at Dec 1, 2020 to advance our CAN10 program towards clinical trials as quickly as possible,” Göran Forsberg, CEO at Cantargia, said in a press release. Press release.
Byta ljus strömställare volvo v70

Press release 04 Jul, 2019 · Regulatory information Cantargia announce full recruitment of CAN04 monotherapy arm in ongoing phase IIa clinical trial

In a collaboration with Panorama Research on the overall CANxx platform, the engineered antibody was identified from a library of more than 100 well-characterized anti-IL1RAP antibodies. 2020-02-19 · Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support 2 dagar sedan · Notice of annual general meeting in Cantargia AB (publ) PR Newswire STOCKHOLM, April 27, 2021 STOCKHOLM, April 27, 2021 /PRNewswire/ -- The shareholders of Cantargia AB (publ) are invited to the For more information, refer to the notice to the extraordinary general meeting, convened for, inter alia, the nomination committee's proposal and which is announced by a separate press release today. For further information, please contact.

Undvikande anknytning vuxen

This press release does not constitute an offer, or a solicitation of any offer, to buy or subscribe for any securities in the Company in any jurisdiction, neither from Cantargia nor from someone

This press release does not identify or suggest, or purport to identify or suggest, the risks (direct or indirect) that may be … This press release does not constitute an offer, or a solicitation of any offer, to buy or subscribe for any securities in the Company in any jurisdiction, neither from Cantargia nor from someone else. This press release does not constitute or form part of an offer or solicitation to purchase or subscribe for securities in the United States. All News Blogs Videos Press Releases.